Skip to main content

Table 2 Association between the VNS system used and the treatment outcomes

From: Safety and effectiveness of vagus nerve stimulation in patients with drug-resistant epilepsy: a single center experience

 

VNS System

P value

102

102/102/105

102/103

102/103/105

102/103/106/106

102/105

102/106

102/106/106

102\103

103

103/106

103\106\106

106

106/106

Seizure Response, No

 < 50 (n = 30)

5.00

0.00

1.00

0.00

0.00

0.00

1.00

0.00

0.00

6.00

4.00

0.00

13.00

0.00

0.63

 > 50 (n = 73)

17.00

1.00

4.00

1.00

1.00

1.00

8.00

2.00

1.00

9.00

4.00

1.00

20.00

3.00

EEG improvement, No

No improvement (n = 41)

7.00

0.00

1.00

0.00

0.00

0.00

3.00

1.00

0.00

7.00

5.00

0.00

15.00

2.00

0.78

Resolution of IEDs (n = 62)

15.00

1.00

4.00

1.00

1.00

1.00

6.00

1.00

1.00

8.00

3.00

1.00

18.00

1.00

QOLIE-31 cognitive subdomain score, No

Below average (n = 3)

0.00

0.00

1.00

0.00

0.00

0.00

1.00

1.00

0.00

0.00

0.00

0.00

0.00

0.00

0.01

Borderline (n = 9)

4.00

1.00

1.00

1.00

0.00

0.00

2.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Low (n = 3)

0.00

0.00

1.00

0.00

0.00

0.00

1.00

1.00

0.00

0.00

0.00

0.00

0.00

0.00

Mild (n = 2)

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

2.00

0.00

Normal (n = 85)

17.00

0.00

2.00

0.00

1.00

1.00

5.00

0.00

1.00

15.00

8.00

1.00

31.00

3.00

Poor (n = 1)

1.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

QOLIE-31 total score, mean ± SD

40.36 ± 9.90

62.00

54.00

69.00

59.00

NR

49.29 ± 17.40

64.00

37.00

39.30 ± 16.60

32.00

18.00

35.04 ± 10.20

38.00 ± 7.90

0.008